The fate of SU-13197, a new antiarrhythmic drug, in rat and man.
D000284:Administration, Oral; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D001552:Benzazepines / Q000378:metabolism*; D001646:Bile / Q000378:metabolism; D001711:Biotransformation; D002247:Carbon Isotopes; D002855:Chromatography, Thin Layer; D005243:Feces / Q000032:analysis; D005260:Female; D005965:Glucuronates / Q000652:urine; D006207:Half-Life; D006801:Humans; D007093:Imidazoles / Q000378:metabolism; D007275:Injections, Intravenous; D008297:Male; D051381:Rats
D000889:Anti-Arrhythmia Agents; D001552:Benzazepines; D002247:Carbon Isotopes; D005965:Glucuronates; D007093:Imidazoles